Losses shrinking while the business grows: the path to self-funding is visible in the numbers being reported, powered by
The model's full reasoning — Q2 2022 call → NOWe need answer only YES or NO. Need evaluate transcript. Company Treace Medical. Q2 2022 revenue $30M, 45% growth. Net loss $17.2M vs $5.1M loss prior year? Wait net loss increased significantly. But adjusted net loss $12.8M vs? They had debt extinguishment loss. Operating expenses increased. They are investing heavily. Losses widened, not shrinking. They mention "sufficient liquidity to fund us into profitability" but not near. They raised guidance. But condition 1: losses meaningfully narrower? No, net loss increased from $5.1M to $17.2M (though includes debt extinguishment $4.5M, adjusted $12.8M vs? Prior year maybe? Not given). Operating expenses increased. They are not yet profitable, but gap is not closing; losses widened due to investments. They expect leverage in middle of P&L as scale, but not showing. They say "we look forward to driving increasing leverage" future. No mention of losses shrinking. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| ANGO | AngioDynamics, Inc. | Q1 2024 | 2023-10-04 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| ULCC | Frontier Group Holdings, Inc. | Q1 2023 | 2023-05-07 | C+ |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| AMC | AMC Entertainment Holdings, Inc. | Q2 2021 | 2021-08-09 | D |
| BCOV | Brightcove Inc. | Q1 2018 | 2018-04-26 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| VRNS | Varonis Systems, Inc. | Q2 2016 | 2016-08-09 | B+ |
BCOV · Q1 2018 → YESThe question is about whether Brightcove on this earnings call fits a specific profile: still unprofitable or only marginally profitable, but losses shrinking due to business growth, and profitability...YES The transcript shows Brightcove is still not comfortably profitable (Q1 non-GAAP operating loss $74k vs $2.6M prior year, full-year guidance crossing from loss to income), with the gap visibly closing in reported results. Growth is the primary driver: revenue $41.
MNKD · Q4 2023 → YESThe question is about whether MannKind Corporation, based on the earnings call transcript, fits this specific description: still unprofitable or only marginally profitable, but losses shrinking due to...
TOST · Q4 2022 → YESThe question is about whether Toast, Inc. from this earnings call fits a specific profile: still unprofitable or only marginally profitable, but losses shrinking visibly due to business growth, and pr...